Lilly CEO Is Optimistic on Cancer, Diabetes Drugs

July 24 (Bloomberg) -- John Lechleiter, chief executive officer of Eli Lilly & Co., talks with Bloomberg's Olivia Sterns about the company's second-quarter results, drugs and growth strategy. Lilly raised its full-year forecast after second-quarter sales grew faster than expected and cost-cutting programs took effect. (Source: Bloomberg)
The Benefits of EMV Credit Card Chip Technology
27:01 - Ellen Richey, Visa's chief enterprise risk officer, explains the benefits of EMV credit card chip technology. She speaks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • ‘The Martian’: $108 Million Movie Debuts This Weekend
  • What’s Behind the Labor Market is Slow Down?
  • How GE Is Appealing to the Tech Audience